MARKET

NURO

NURO

NeuroMetrix
NASDAQ

Real-time Quotes | Nasdaq Last Sale

11.34
+0.46
+4.23%
After Hours: 11.10 -0.24 -2.12% 19:59 09/17 EDT
OPEN
10.77
PREV CLOSE
10.88
HIGH
11.34
LOW
10.45
VOLUME
744.19K
TURNOVER
--
52 WEEK HIGH
38.75
52 WEEK LOW
1.390
MARKET CAP
63.83M
P/E (TTM)
-38.1048
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers
Benzinga · 09/01 23:34
EDU, TAL and MMAT among pre market gainers
Vinco Ventures (NASDAQ:BBIG) +65%. Aterian (NASDAQ:ATER) +52%. Support.com (NASDAQ:SPRT) +45%. Affirm Holdings (NASDAQ:AFRM) +40% as Amazon to integrate pay-over-time into its cart Globalstar (NYSE:GSAT) +36% on report iPhone 13 may use satellite connectiv...
Seekingalpha · 08/30 12:31
28 Stocks Moving in Monday's Pre-Market Session
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) rose 86.1% to $9.87 in pre-market trading after jumping over 80% on Friday. The company recently reported a Q2 loss of $5.13 per share.
Benzinga · 08/30 11:05
60 Biggest Movers From Yesterday
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.
Benzinga · 08/30 09:18
Neurometrix Inc (NURO) Senior Vice President, CFO Thomas T Higgins Sold $527,500 of Shares
GuruFocus News · 08/28 13:15
What's Going On With NeuroMetrix Shares Today?
NeuroMetrix Inc (NASDAQ: NURO) shares are surging higher Friday on abnormally high volume amid an increase in retail investor interest around the low-float stock.
Benzinga · 08/27 16:58
NuroMetrix Pushes Higher Friday: What's Next?
NuroMetrix Inc. (NASDAQ: NURO) shares are trading higher Friday after the company began seeing increased retail interest in the stock. The stock has been seeing above average volume the past couple of days and was trending on social media sites throughout ...
Benzinga · 08/27 16:43
35 Stocks Moving In Friday's Mid-Day Session
Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The stock has recently been mentioned as a potential short squeeze play by traders on social media. Navios Maritime Acquisition Corpo...
Benzinga · 08/27 16:04
More
Forecast
Actual (K USD)
Estimate (K USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NURO. Analyze the recent business situations of NeuroMetrix through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NURO stock price target is 50.00 with a high estimate of 50.00 and a low estimate of 50.00.
EPS
Institutional Holdings
Institutions: 28
Institutional Holdings: 433.57K
% Owned: 7.70%
Shares Outstanding: 5.63M
TypeInstitutionsShares
Increased
6
82.64K
New
4
7.12K
Decreased
2
271
Sold Out
2
35.96K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.10%
Healthcare Equipment & Supplies
+0.65%
Key Executives
Chairman/Chief Executive Officer/President/Secretary/Director
Shai Gozani
Chief Financial Officer/Senior Vice President/Treasurer
Thomas Higgins
Independent Director
David Goodman
Independent Director
Nancy Katz
Independent Director
David Van Avermaete
Declaration Date
Dividend Per Share
Ex-Div Date
03/14/2007
Dividend USD 0.15
03/28/2007
About NURO
NeuroMetrix, Inc. is a healthcare company combining bioelectrical and digital medicine to address chronic health conditions, including chronic pain, sleep disorders and diabetes. The Company is engaged in the sale of medical equipment, and consumables and accessories. It has two principal product lines: Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. Its products include ADVANCE NCS/EMG System (the ADVANCE System), Quell, SENSUS and DPNCheck. Quell is a wearable device for relief of chronic intractable pain, such as nerve pain due to diabetes and lower back problems. The SENSUS pain therapy device, the technological predecessor to Quell, is a prescription neuro-stimulation device based on transcutaneous electrical nerve stimulation (TENS) for relief of chronic, intractable pain. DPNCheck is a quantitative nerve conduction test. ADVANCE System is a platform for the performance of traditional nerve conduction studies.

Webull offers kinds of Neurometrix Inc stock information, including NASDAQ:NURO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NURO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NURO stock methods without spending real money on the virtual paper trading platform.